BridgeBio Oncology Therapeutics, Inc. · NASDAQ:BBOT
Beltran Pedro sold 1,870 BridgeBio Oncology Therapeutics, Inc. shares (Form 4)
Traded Nov 18, 2026 · Filed Nov 20, 2026
On Nov 18, 2026, Beltran Pedro (Director, President and CEO) sold 1,870 BridgeBio Oncology Therapeutics, Inc. shares at US$1.84 for US$3,443 under a trading plan, leaving 41,659 shares. Filed Nov 20, 2026 (Form 4).
- Sold
- 1,870 shares
- Price
- US$1.84
- Value
- US$3,443
- Holding after
- 41,659 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | Common Stock | Sale | 1,870 | US$1.84 | 41,659 | Direct |
Source
Download original · View original at SEC
Related
- BridgeBio Oncology Therapeutics, Inc.
- Beltran Pedro
- BridgeBio Oncology Therapeutics, Inc. shareholders
- Form 4 · Beltran Pedro · Oct 5, 2026
- Form 4 · Beltran Pedro · Jul 6, 2026
- Form 4 · Beltran Pedro · May 5, 2026
- Form 4 · Cobo Marc · Nov 17, 2026
- Schedule 13G/A · Deerfield Management Company, L.P. · Nov 13, 2026
- Form 4 · Cobo Marc · Oct 23, 2026
- Form 4 · Ben Yong · Oct 5, 2026
- Form 4 · Elmelech Idan · Oct 5, 2026